BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

976 related articles for article (PubMed ID: 10360171)

  • 1. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR.
    Wang H; Chen J; Hollister K; Sowers LC; Forman BM
    Mol Cell; 1999 May; 3(5):543-53. PubMed ID: 10360171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bile acids: natural ligands for an orphan nuclear receptor.
    Parks DJ; Blanchard SG; Bledsoe RK; Chandra G; Consler TG; Kliewer SA; Stimmel JB; Willson TM; Zavacki AM; Moore DD; Lehmann JM
    Science; 1999 May; 284(5418):1365-8. PubMed ID: 10334993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a nuclear receptor for bile acids.
    Makishima M; Okamoto AY; Repa JJ; Tu H; Learned RM; Luk A; Hull MV; Lustig KD; Mangelsdorf DJ; Shan B
    Science; 1999 May; 284(5418):1362-5. PubMed ID: 10334992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
    Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
    Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the enterohepatic circulation of bile salts and nuclear hormone receptors in the regulation of cholesterol homeostasis: Bile salts as ligands for nuclear hormone receptors.
    Redinger RN
    Can J Gastroenterol; 2003 Apr; 17(4):265-71. PubMed ID: 12704471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FXR, a bile acid receptor and biological sensor.
    Tu H; Okamoto AY; Shan B
    Trends Cardiovasc Med; 2000 Jan; 10(1):30-5. PubMed ID: 11150726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bile salt excretory pump: biology and pathobiology.
    Suchy FJ; Ananthanarayanan M
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S10-6. PubMed ID: 16819395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis.
    Sinal CJ; Tohkin M; Miyata M; Ward JM; Lambert G; Gonzalez FJ
    Cell; 2000 Sep; 102(6):731-44. PubMed ID: 11030617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand-dependent coactivation of the human bile acid receptor FXR by the peroxisome proliferator-activated receptor gamma coactivator-1alpha.
    Savkur RS; Thomas JS; Bramlett KS; Gao Y; Michael LF; Burris TP
    J Pharmacol Exp Ther; 2005 Jan; 312(1):170-8. PubMed ID: 15329387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coordinated control of bile acids and lipogenesis through FXR-dependent regulation of fatty acid synthase.
    Matsukuma KE; Bennett MK; Huang J; Wang L; Gil G; Osborne TF
    J Lipid Res; 2006 Dec; 47(12):2754-61. PubMed ID: 16957179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of DRIP205 as a coactivator for the Farnesoid X receptor.
    Pineda Torra I; Freedman LP; Garabedian MJ
    J Biol Chem; 2004 Aug; 279(35):36184-91. PubMed ID: 15187081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of gene-selective modulators of the bile acid receptor FXR.
    Dussault I; Beard R; Lin M; Hollister K; Chen J; Xiao JH; Chandraratna R; Forman BM
    J Biol Chem; 2003 Feb; 278(9):7027-33. PubMed ID: 12496277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nuclear bile acid receptor FXR is activated by PGC-1alpha in a ligand-dependent manner.
    Kanaya E; Shiraki T; Jingami H
    Biochem J; 2004 Sep; 382(Pt 3):913-21. PubMed ID: 15202934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of farnesoid X receptor coactivator recruitment and cholesterol 7alpha-hydroxylase gene repression by bile acids.
    Bramlett KS; Yao S; Burris TP
    Mol Genet Metab; 2000 Dec; 71(4):609-15. PubMed ID: 11136553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T0901317 is a dual LXR/FXR agonist.
    Houck KA; Borchert KM; Hepler CD; Thomas JS; Bramlett KS; Michael LF; Burris TP
    Mol Genet Metab; 2004; 83(1-2):184-7. PubMed ID: 15464433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationship of bile acids and bile acid analogs in regard to FXR activation.
    Fujino T; Une M; Imanaka T; Inoue K; Nishimaki-Mogami T
    J Lipid Res; 2004 Jan; 45(1):132-8. PubMed ID: 13130122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Farnesoid x receptor ligands inhibit vascular smooth muscle cell inflammation and migration.
    Li YT; Swales KE; Thomas GJ; Warner TD; Bishop-Bailey D
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2606-11. PubMed ID: 18029909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FXR: a metabolic regulator and cell protector.
    Wang YD; Chen WD; Moore DD; Huang W
    Cell Res; 2008 Nov; 18(11):1087-95. PubMed ID: 18825165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxysterol 22(R)-hydroxycholesterol induces the expression of the bile salt export pump through nuclear receptor farsenoid X receptor but not liver X receptor.
    Deng R; Yang D; Yang J; Yan B
    J Pharmacol Exp Ther; 2006 Apr; 317(1):317-25. PubMed ID: 16371446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of FXR in regulating bile acid homeostasis and relevance for human diseases.
    Rizzo G; Renga B; Mencarelli A; Pellicciari R; Fiorucci S
    Curr Drug Targets Immune Endocr Metabol Disord; 2005 Sep; 5(3):289-303. PubMed ID: 16178789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.